107 related articles for article (PubMed ID: 16753865)
1. Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia.
Chim CS; Kwong YL
Leuk Lymphoma; 2006 May; 47(5):815-25. PubMed ID: 16753865
[TBL] [Abstract][Full Text] [Related]
2. CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia.
Chim CS; Lau JS; Wong KF; Kwong YL
Leukemia; 2006 Jan; 20(1):149-51. PubMed ID: 16307009
[No Abstract] [Full Text] [Related]
3. p15
Baba SM; Azad NA; Shah ZA; Dil-Afroze ; Pandith AA; Jan A; Aziz SA
Cancer Res Treat; 2017 Jul; 49(3):790-797. PubMed ID: 28052659
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis.
Teofili L; Martini M; Luongo M; Diverio D; Capelli G; Breccia M; Lo Coco F; Leone G; Larocca LM
Leukemia; 2003 May; 17(5):919-24. PubMed ID: 12750706
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
6. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
7. Serial studies of methylation of CDKN2B and CDKN2A in relapsed acute promyelocytic leukaemia treated with arsenic trioxide.
Au WY; Fung AT; Ma ES; Chan CH; Wong KF; Chim CS; Liang RH; Kwong YL
Br J Haematol; 2005 Dec; 131(5):632-5. PubMed ID: 16351640
[TBL] [Abstract][Full Text] [Related]
8. Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance.
Chim CS; Wong SY; Kwong YL
Br J Haematol; 2003 Aug; 122(4):571-8. PubMed ID: 12899712
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
[TBL] [Abstract][Full Text] [Related]
10. Effects of Novel ncRNA Molecules, p15-piRNAs, on the Methylation of DNA and Histone H3 of the CDKN2B Promoter Region in U937 Cells.
Wu D; Fu H; Zhou H; Su J; Zhang F; Shen J
J Cell Biochem; 2015 Dec; 116(12):2744-54. PubMed ID: 26205624
[TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia.
Chim CS; Wong SY; Pang A; Chu P; Lau JS; Wong KF; Kwong YL
Leukemia; 2005 Dec; 19(12):2241-6. PubMed ID: 16239915
[TBL] [Abstract][Full Text] [Related]
12. Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance.
Chim CS; Liang R; Tam CY; Kwong YL
J Clin Oncol; 2001 Apr; 19(7):2033-40. PubMed ID: 11283136
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of epigenetic silencing of p15INK4B in acute promyelocytic leukemia.
Garcia-Manero G
Leukemia; 2003 May; 17(5):839-40. PubMed ID: 12750694
[No Abstract] [Full Text] [Related]
14. DNA methylation at the 9p21 glaucoma susceptibility locus is associated with normal-tension glaucoma.
Burdon KP; Awadalla MS; Mitchell P; Wang JJ; White A; Keane MC; Souzeau E; Graham SL; Goldberg I; Healey PR; Landers J; Mills RAD; Best S; Hewitt AW; Sharma S; Craig JE
Ophthalmic Genet; 2018 Apr; 39(2):221-227. PubMed ID: 29265947
[TBL] [Abstract][Full Text] [Related]
15. Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators.
Herrera-Moreno JF; Medina-Díaz IM; Bernal-Hernández YY; Ramos KS; Alvarado-Cruz I; Quintanilla-Vega B; González-Arias CA; Barrón-Vivanco BS; Rojas-García AE
Environ Sci Pollut Res Int; 2019 May; 26(15):15124-15135. PubMed ID: 30924039
[TBL] [Abstract][Full Text] [Related]
16. Quantitative high-resolution CpG island mapping with Pyrosequencing reveals disease-specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemia.
Brakensiek K; Wingen LU; Länger F; Kreipe H; Lehmann U
Clin Chem; 2007 Jan; 53(1):17-23. PubMed ID: 17095538
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of p15 gene aberrations in acute leukemia.
De Braekeleer M; Douet-Guilbert N; De Braekeleer E
Leuk Lymphoma; 2017 Feb; 58(2):257-265. PubMed ID: 27401303
[TBL] [Abstract][Full Text] [Related]
19. Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes.
Kim M; Kook H; Park HJ; Ahn HS; Lee KC; Lee KS; Park SK; Lim JY; Kim HK; Han DK; Lee DS;
Acta Haematol; 2013; 130(2):115-21. PubMed ID: 23571652
[TBL] [Abstract][Full Text] [Related]
20. [Methylation of the genes in the 9P21 region in children with acute myeloid leukemia].
Zhang L; Ruan M; Liu XM; Zhang JY; Guo Y; Yang WY; Liu F; Liu TF; Wang SC; Chen XJ; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):6-10. PubMed ID: 25616284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
